|
Market Closed -
Nasdaq
23:00:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 586.48 USD | -0.80% |
|
+4.08% | +20.37% |
| 10-29 | United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing | MT |
| 10-28 | United Therapeutics Wins FDA Clearance for Treprostinil-Iloprost Phase 1 Trial | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
|
Boerse Muenchen
| UTH | Real-time | |
|
Deutsche Boerse AG
| UTH | Delayed | |
|
Tradegate
| UTH | Real-time | |
|
Börse Stuttgart
| UTH | Delayed | |
|
Berne S.E.
| UTH | End-of-day quote | |
|
Xetra
| UTH | Delayed | |
Sao Paulo
| U2TH34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 596.76 | 596.76 | 588.38 |
| Spread/Res. | -1.72% | -1.72% | -0.32% |
| Spread/Supp. | +10.01% | +24.20% | +26.14% |
| Support | 533.12 | 472.21 | 464.93 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UTHR Stock
- Charts United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
